Alisertib and Combination Chemotherapy in Treating Patients With Gastrointestinal Tumors

Clinical trial NCT02319018 · COMPLETED

Trial details

NCT number: NCT02319018
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Digestive System Neoplasm

Start date: 2015-08-27
Primary completion: 2018-09-29
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.